Neurovascular Devices/Interventional Neurology Market

1. Executive Summary

2. Introduction
     2.1. Study Objectives
     2.2. Market Definition
          2.2.1. Market Covered
          2.2.2. Geographical Coverage
          2.2.3. Study Years & Currency
     2.3. Market Stakeholders
     2.4. Key Questions this Study will Answer
     2.5. GMI Research’s Approach & Methodology

3. Global Neurovascular Devices/Interventional Neurology Market - Overview
     3.1. Introduction
     3.2. Market Segmentation
     3.3. Value Chain Analysis
     3.4. Drivers
     3.5. Restraints
     3.6. Trends

4. Global Neurovascular Devices/Interventional Neurology Market Revenue Forecast till 2026

5. Global Neurovascular Devices/Interventional Neurology Market by Product Revenue Forecast till 2026
     5.1. Aneurysm Coiling & Embolization Devices
     5.2. Cerebral Balloon Angioplasty and Stenting Systems
     5.3. Support Devices
     5.4. Neurothrombectomy Devices

6. Global Neurovascular Devices/Interventional Neurology Market by Disease Pathology Revenue Forecast till 2026
     6.1. Ischemic Strokes
     6.2. Cerebral Aneurysms
     6.3. Arteriovenous Malformation and Fistulas
     6.4. Other Disease Pathologies

7. Global Neurovascular Devices/Interventional Neurology Market by End User Revenue Forecast till 2026
     7.1. Hospitals
     7.2. Clinics
     7.3. Ambulatory Surgical Centers

8. Global Neurovascular Devices/Interventional Neurology Market by Geography Revenue Forecast till 2026
     8.1. North America Neurovascular Devices/Interventional Neurology Market Revenue Forecast till 2026
          8.1.1. North America Neurovascular Devices/Interventional Neurology Market by Product (Option 1: 25% customization)
                    8.1.1.1. Aneurysm Coiling & Embolization Devices
                    8.1.1.2. Cerebral Balloon Angioplasty and Stenting Systems
                    8.1.1.3. Support Devices
                    8.1.1.4. Neurothrombectomy Devices

          8.1.2. North America Neurovascular Devices/Interventional Neurology Market by Disease Pathology
                    8.1.2.1. Ischemic Strokes
                    8.1.2.2. Cerebral Aneurysms
                    8.1.2.3. Arteriovenous Malformation and Fistulas
                    8.1.2.4. Other Disease Pathologies

          8.1.3. North America Neurovascular Devices/Interventional Neurology Market by End User
                    8.1.3.1. Hospitals
                    8.1.3.2. Clinics
                    8.1.3.3. Ambulatory Surgical Centers

     8.2. Europe Neurovascular Devices/Interventional Neurology Market Revenue Forecast till 2026
          8.2.1. Europe Neurovascular Devices/Interventional Neurology Market by Product (Option 2: 25% customization)
                    8.2.1.1. Aneurysm Coiling & Embolization Devices
                    8.2.1.2. Cerebral Balloon Angioplasty and Stenting Systems
                    8.2.1.3. Support Devices
                    8.2.1.4. Neurothrombectomy Devices
          8.2.2. Europe Neurovascular Devices/Interventional Neurology Market by Disease Pathology
                    8.2.2.1. Ischemic Strokes
                    8.2.2.2. Cerebral Aneurysms
                    8.2.2.3. Arteriovenous Malformation and Fistulas
                    8.2.2.4. Other Disease Pathologies

          8.2.3. Europe Neurovascular Devices/Interventional Neurology Market by End User
                    8.2.3.1. Hospitals
                    8.2.3.2. Clinics
                    8.2.3.3. Ambulatory Surgical Centers

     8.3. Asia-Pacific Neurovascular Devices/Interventional Neurology Market Revenue Forecast till 2026
          8.3.1. Asia-Pacific Neurovascular Devices/Interventional Neurology Market by Product (Option 3: 25% customization)
                    8.3.1.1. Aneurysm Coiling & Embolization Devices
                    8.3.1.2. Cerebral Balloon Angioplasty and Stenting Systems
                    8.3.1.3. Support Devices
                    8.3.1.4. Neurothrombectomy Devices

          8.3.2. Asia-Pacific Neurovascular Devices/Interventional Neurology Market by Disease Pathology
                    8.3.2.1. Ischemic Strokes
                    8.3.2.2. Cerebral Aneurysms
                    8.3.2.3. Arteriovenous Malformation and Fistulas
                    8.3.2.4. Other Disease Pathologies

          8.3.3. Asia-Pacific Neurovascular Devices/Interventional Neurology Market by End User
                    8.3.3.1. Hospitals
                    8.3.3.2. Clinics
                    8.3.3.3. Ambulatory Surgical Centers

     8.4. Rest of the World Neurovascular Devices/Interventional Neurology Market Revenue Forecast till 2026
          8.4.1. Rest of the World Neurovascular Devices/Interventional Neurology Market by Product (Option 4: 25% customization)
                    8.4.1.1. Aneurysm Coiling & Embolization Devices
                    8.4.1.2. Cerebral Balloon Angioplasty and Stenting Systems
                    8.4.1.3. Support Devices
                    8.4.1.4. Neurothrombectomy Devices

          8.4.2. Rest of the World Neurovascular Devices/Interventional Neurology Market by Disease Pathology
                    8.4.2.1. Ischemic Strokes
                    8.4.2.2. Cerebral Aneurysms
                    8.4.2.3. Arteriovenous Malformation and Fistulas
                    8.4.2.4. Other Disease Pathologies

          8.4.3. Rest of the World Neurovascular Devices/Interventional Neurology Market by End User
                    8.4.3.1. Hospitals
                    8.4.3.2. Clinics
                    8.4.3.3. Ambulatory Surgical Centers

9. Competitive Landscape Analysis

10. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
       10.1. Stryker Corporation
             10.1.1. Company Overview
             10.1.2. Financials
             10.1.3. Recent Developments

       10.2. Medtronic PLC
             10.2.1. Company Overview
             10.2.2. Financials
             10.2.3. Recent Developments

       10.3. Johnson & Johnson
             10.3.1. Company Overview
             10.3.2. Financials
             10.3.3. Recent Developments

       10.4. Terumo Corporation
             10.4.1. Company Overview
             10.4.2. Financials
             10.4.3. Recent Developments

       10.5. Penumbra Inc.
             10.5.1. Company Overview
             10.5.2. Financials
             10.5.3. Recent Developments

       10.6. Boston Scientific Corporation
             10.6.1. Company Overview
             10.6.2. Financials
             10.6.3. Recent Developments

       10.7. Microport Scientific Corporation
             10.7.1. Company Overview
             10.7.2. Financials
             10.7.3. Recent Developments

       10.8. Merit Medical Systems Inc.
             10.8.1. Company Overview
             10.8.2. Financials
             10.8.3. Recent Developments

       10.9. Abbott Laboratories
             10.9.1. Company Overview
             10.9.2. Financials
             10.9.3. Recent Developments

       10.10. W.L. Gore & Associates Inc.
             10.10.1. Company Overview
             10.10.2. Financials
             10.10.3. Recent Developments

11. About GMI Research